Elizabeth Ofili to Blood Glucose
This is a "connection" page, showing publications Elizabeth Ofili has written about Blood Glucose.
Connection Strength
1.010
-
Pemu P, Josiah Willock R, Alema-Mensa E, Rollins L, Brown M, Saint Clair B, Olorundare E, McCaslin A, Henry Akintobi T, Quarshie A, Ofili E. Achieving Health Equity with e-Healthystrides?: Patient Perspectives of a Consumer Health Information Technology Application. Ethn Dis. 2019; 29(Suppl 2):393-404.
Score: 0.611
-
Ofili EO, Pemu PE, Quarshie A, Mensah EA, Rollins L, Ojutalayo F, McCaslin A, Clair BS. DEMOCRATIZING DISCOVERY HEALTH WITH N=Me. Trans Am Clin Climatol Assoc. 2018; 129:215-234.
Score: 0.138
-
Ofili EO, Zappe DH, Purkayastha D, Samuel R, Sowers JR. Antihypertensive and metabolic effects of Angiotensin receptor blocker/diuretic combination therapy in obese, hypertensive African American and white patients. Am J Ther. 2013 Jan; 20(1):2-12.
Score: 0.098
-
Floyd B, Chandra P, Hall S, Phillips C, Alema-Mensah E, Strayhorn G, Ofili EO, Umpierrez GE. Comparative analysis of the efficacy of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes mellitus. J Diabetes Sci Technol. 2012 Sep 01; 6(5):1094-102.
Score: 0.096
-
Idris MY, Alema-Mensah E, Olorundare E, Mohammad M, Brown M, Ofili E, Pemu P. Exploring the Discursive Emphasis on Patients and Coaches Who Participated in Technology-Assisted Diabetes Self-management Education: Clinical Implementation Study of Health360x. J Med Internet Res. 2022 03 18; 24(3):e23535.
Score: 0.046
-
Sowers JR, Raij L, Jialal I, Egan BM, Ofili EO, Samuel R, Zappe DH, Purkayastha D, Deedwania PC. Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives. J Hypertens. 2010 Aug; 28(8):1761-9.
Score: 0.021